Electronic versus Combustible Cigarette Effects on Inflammasome Component Release into Human Lung.
Electronic versus Combustible Cigarette Effects on Inflammasome Component Release into Human Lung.
复制标题
电子香烟与可燃香烟对炎症体成分释放到人肺中的影响。
DOI:
10.1164/rccm.201808-1467le
复制
发表时间:
2019
影响因子:
24.7
通讯作者:
Wewers,MarkD
中科院分区:
文献类型:
--
作者:
Tsai,MuChun;Song,Min-Ae;McAndrew,Christian;Brasky,TheodoreM;Freudenheim,JoL;Mathé,Ewy;McElroy,Joseph;Reisinger,SarahA;Shields,PeterG;Wewers,MarkD
MethodsForty-three normal subjects composed of smokers, never-smokers, and e-cigarette users (Tables 1 and 2) underwent elective bronchoscopy with 100–140 ml saline BAL fluid after Institutional Review Board (IRB 2015C0088)–approved informed consent, as part of a larger study analyzing the effects of e-cigarettes on lung biomarkers. Smokers were delineated as those who smoked at least 10 cigarettes a day for at least 6 months with no prior e-cigarette use within a year. E-cigarette users were defined as nonsmokers who used at least one nicotine-containing cartridge per day or 1 ml liquid per day for at least 3 months, 12 of whom were former smokers (> 5 mo; mean= 8 yr). Never-smokers had smoked fewer than 100 cigarettes in their lifetime, and not for at least 1 year, with no e-cigarette use within that timeframe. Nonsmoking status was confirmed by salivary cotinine (NicAlert; Nymox Pharmaceuticals). All participants were randomly assigned to the right or left lung for bronchoscopy in a 1: 1 ratio within each smoking status group (never-smokers, e-cigarette users, and smokers). BAL fluid samples were spun down at 300g at 4 C to separate cells from the supernatant. Cell-free lavage fluid was stored in aliquots and frozen at− 80 C until processed. BAL fluid was analyzed by sandwich ELISAs for ASC and caspase-1 combining commercial mouse monoclonal with rabbit polyclonal detection antibodies generated in our laboratory (4) and a bead-based ELISA for IL-1β (Meso Scale Discovery).